1256819-03-0

Basic information

• Product Name: 5-BroMo-3-ethoxy-2-Methyl-pyridine
• Synonyms: 5-BroMo-3-ethoxy-2-Methyl-pyridine
• CAS NO: 1256819-03-0
• Molecular Formula: C₈H₁₀BrNO
• Molecular Weight: 216.0751
• Mol File: 1256819-03-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BroMo-3-ethoxy-2-Methyl-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BroMo-3-ethoxy-2-Methyl-pyridine(1256819-03-0)
• EPA Substance Registry System: 5-BroMo-3-ethoxy-2-Methyl-pyridine(1256819-03-0)

Safety Data

• Hazardous Substances Data: 1256819-03-0(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 914358-73-9 5-bromo-2-methylpyridin-3-ylamine 
• 75-03-6 ethyl iodide 
• 91420-25-6 2-methyl-3-hydroxy-5-bromopyridine 
• 67443-38-3 5-bromo-2-chloro-3-nitropyridine 
• 911434-05-4 5-bromo-2-methyl-3-nitropyridine 

Relevant articles and documents

HETEROARYLS AND USES THEREOF

The present invention provides a compound of formula I: and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4, R5, L1, L2, m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

HETEROARYLS AND USES THEREOF

The present invention provides a compound of formula I: and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4, R5, L1, L2, m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE

The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to the use of 1 H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1 H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1 H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1 H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1 H-imidazo[4,5-c]quinolinone compounds.